Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1994 | |
| Cash Flows From Operating Activities | |
| Net Income | -4,071 |
| Depreciation Amortization | 153 |
| Other Working Capital | 402 |
| Other Operating Activity | 89 |
| Operating Cash Flow | $-3,427 |
| Cash Flows From Investing Activities | |
| PPE Investments | -574 |
| Other Investing Activity | 2,807 |
| Investing Cash Flow | $2,233 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | -15 |
| Financing Cash Flow | $-15 |
| Beginning Cash Position | 2,915 |
| End Cash Position | 1,706 |
| Net Cash Flow | $-1,209 |
| Free Cash Flow | |
| Operating Cash Flow | -3,427 |
| Free Cash Flow | -3,427 |